Background This study describes the impact of clinical, angiographic, and demographic characteristics on the longterm survival of Coronary Artery Surgery Study (CASS) patients while they were under medical treatment. Revascularization rates for the population are also provided.
W ith nearly 25 000 patients in its registry, de- tailed data collection, and excellent follow-up rates (95.8% for vital status), the National Heart, Lung, and Blood Institute's Coronary Artery Surgery Study (CASS) registry is an important source of information on patients with angiographically proven coronary artery disease. Detailed analyses of the coronary arteriograms and left ventriculograms have made possible accurate classification of patients according to extent of coronary artery disease and left ventricular function. It is important to obtain as precise a classification as possible when describing variation in the natural history of coronary artery disease or when considering therapy on the basis of long-term survival. In this article, we report the impact of patient characteristics on long-term survival while they were under medical therapy or surveillance. Follow-up time ranged from 0 to 17 years, with a median of 12 years. The large study population and the extended observation time make it possible to estimate the independent effects of many variables simultaneously. This report updates and expands our previous report of 4-year survival in medically treated CASS patients.'
Also reported are associations between patient characteristics and the election of coronary artery bypass graft surgery (CABG) . In addition to depicting the surgical decision practices at the time in this population, the surgery analysis provides information on which members of the medically treated population were more likely to be withdrawn from strictly medical therapy. Although percutaneous transluminal coronary angioplasty (PTCA) was not available until well after follow-up of the study patients began, for completeness and historical purposes the number of patients receiving PTCA in this population is also reported.
Methods Population and Data Collection
The CASS database contains 24 959 patients who were admitted to 15 clinical centers with suspected or proven coronary artery disease between 1974 and 1979. This report is based on an analysis of patients who had not had coronary surgery before enrollment. The CASS design, methods, and database have been described in detail.2 All patients underwent coronary angiography performed by either the brachial or the femoral technique, and multiple views of each vessel were obtained. The extent of arterial stenosis, given as a percentage of maximal area of the luminal diameter, was recorded for each of 27 coronary artery segments. The criterion for clinically significant one-, two-, or three-vessel coronary artery obstruction was either .70% reduction in the internal diameter of the right or left anterior descending or left circumflex coronary artery or .50% reduction in the internal diameter of the left main coronary artery (LMCA). The ejection fraction was calculated from left ventricular angiograms and provided a good global measurement of left ventricular function. Not all patients had determinations of ejection fraction, primarily because of technical and logistic reasons.
Associations between baseline variables and two end points are examined in this study: (1) death from any cause (the "survival analysis") and (2) first CABG surgery (the "surgery analysis"). A third end point, subsequent PTCA, was analyzed only in relation to other treatments received and not according to patients' enrollment characteristics. The study population for the survival analysis includes all CASS patients who had not had coronary surgery previous to enrollment (n=23 467). Patients who initially received medical treatment but later had CABG or PTCA were withdrawn from further analysis at the time of revascularization. Most often, subsequent revascularization was performed because of the failure of medical therapy to adequately control the patient's symptoms. Except for the 780 patients who participated in the CASS randomized trial comparing CABG with medical treatment,3 the decision for surgical or medical therapy was made by the study physicians and the patients. Since most CASS patients were not randomized, the decision to treat a patient medically or surgically was determined for most patients by prevailing clinical opinion. Given the large sample size, the data presented in this study are viewed as being representative of clinical practice at the participating clinical sites in the United States and Canada during the period of enrollment.
Information on vital status was obtained from two sources: the National Death Index and the last CASS follow-up of all patients, a questionnaire mailed to patients between 1988 and 1991. All death dates through 1989 were obtained from the National Death Index. In some cases, later death information was obtained from next of kin who returned the questionnaire. Vital status at the last follow-up date was known for 95.8% of the survival study population. Follow-up time ranged from 0 to 17 years. The percentages of patients having >4, >8, >12, or >16 years of follow-up are 61%, 58%, 47%, and 17%, respectively.
The study population for the surgery analysis included 14 817 patients without previous coronary surgery who had at least one operable coronary vessel at enrollment and who were not part of the concurrent randomized study. The criteria used to determine operability are given in the "Appendix." Information on revascularization (CABG and PTCA) was obtained through 1982 by the annual follow-up procedure described by the CASS investigators and their associates.2 Information on revascularizations taking place after 1982 was obtained by the long-term follow-up questionnaire filled out either by the patient or by health professionals at the participating sites. Revascularization status at the last follow-up was determined for 88% of the population in the surgery analysis.
All patients who had not had coronary surgery previous to enrollment were included in the PTCA analysis.
Statistical Analysis
The association between survival and each of several patient characteristics (variables) was assessed by use of a log-rank test of the hypothesis that survival is the same over all levels of the variable. In some cases, the variable tested consisted of the cross-classification of two other variables. For example, patients were categorized by the number of proximal obstructions within the categories of one-, two-, and three-vessel disease. Survival percentages for different levels of the vanable were estimated via the method of Kaplan and Meier4 and are depicted in the figures. We refer to these as the univariate results. These univariate subanalyses may provide excellent visual displays but are uncorrected for possible confounding variables. To assess the association of each variable with survival while controlling for the effects of other variables, a Cox proportional-hazards regression was performed.5 This constitutes the multivariate analysis. This regression technique estimates the hazard ratio between levels of each variable in the model. Each level of a variable defines a subgroup of patients -for example, those with three-vessel disease. The hazard is approximately the probability of death in a short period of time. The ratio of hazards between two subgroups of patients may be used to compare the mortality between the two subgroups. A hazard ratio of 1 indicates that there is no difference between the subgroups; a hazard ratio >1 (<1) indicates that a person in the designated "risk" subgroup is more (less) likely to die than a person in the designated baseline subgroup, given that all other determinants of survival are the same.
For the regression model, a forward stepwise procedure was used to select significant variables from among the following: number of diseased vessels, number of operable vessels, percent LMCA stenosis, presence of left main equivalent disease, number of proximal diseased vessels, ejection fraction, left ventricular score, myocardial jeopardy score, presence of unstable angina, anginal class (Canadian Heart Association classification or angina unrelated to exertion), congestive heart failure score, history of prior myocardial infarction, smoking status, age, sex, presence of diabetes, and a count of other illnesses. (See the "Appendix" for definitions of these variables.) The significance level to enter the model was P=.10. For the initial stepwise variable selection, all variables except age and illness count were coded in a discrete manner to allow possible nonlinear regression relations and to achieve the most flexible fit. The resulting model was then simplified by collapsing levels witth nearly the same hazard or entering a variable in a continuous manner, if such simplification did not significantly reduce the goodness of fit of the model as measured by the partial likelihood ratio statistic.6 Finally, all possible interactions between sex and each variable in the previous model were allowed to enter in a stepwise fashion.
Patients who had missing values for a variable used in any subanalysis were excluded from that subanalysis. Numbers of patients with complete data are indicated in the figures and tables of results. Significance levels are uncorrected for multiple testing.
A statistical analysis similar to that just described was performed with first CABG used as the end point. For the purpose of estimating coefficients in the surgery regression model, follow-up was truncated to 4 years after enrollment for all patients, since the proportional-hazards assumption did not hold for variables over a more extended period of time. This is expected, because the relevance of each variable recorded at enrollment changes over time but not necessarily in a proportional manner across subgroups of patients. (Lack of proportional hazards does not affect the validity of the log-rank tests or the survival curves.)
The variables in the final survival and surgery models are presented in order of explanatory significance in Tables 1 and  2 , in which explanatory significance is determined by the improvement in the global x2 statistic, which is due to the inclusion of all levels of that variable in the model.
The rate to PTCA analysis for this population was limited, since enrollment, baseline characterization, and initial therapy took place before the availability of PTCA. Reported here is the number of patients eventually undergoing PTCA, classified by other treatments received. An analysis based on patient subgroups formed according to enrollment characteristics would be inappropriate here, since PTCA was not available until approximately 8 years after these characterizations were 
Results

Population Characteristics
The composition of the population studied in the survival analysis, according to characteristics under study, is given in Fig 9) . though the population composition shown in column 2 of Table 3 will change over time because of higher mortality in particular subgroups and loss to a small number of later operations, column 2 of Table 3 gives a good characterization of the CASS population chosen for long-term medical therapy. At enrollment, 75% of the population were male, the average age was 53 years, and 58% were employed full time. Thirty-three percent were currently smoking cigarettes, and another 42% had formerly smoked cigarettes. Thirty-one percent had a cholesterol level >250 mg/dL, 11% had diabetes mellitus, and 48% had a history of myocardial infarction. Seventy-three percent presented with typical anginal chest pain: 5% had Canadian Heart Association class I angina, 22% had class II angina, 26% had class III angina, and 12% had class IV angina. Eight percent had angina unrelated to activity (labeled "rest angina"), and 26% had unstable angina. The percentages of patients having zero-, one-, two-, and three-vessel disease were 29%, 21%, 22%, and 28%, respectively.
Among those for whom ejection fraction was determined, the percentages having ejection fractions in the categories of 50% to 100%, 35% to 49%, and 0% to 34% were 76%, 14%, and 7%, respectively.
The population under medical treatment at 240 days had a larger percentage of female patients, fewer diseased vessels, less angina, fewer LMCA obstructions, fewer proximal obstructions, fewer operable vessels, lower myocardial jeopardy scores, and younger age on average than the population at enrollment. Shifts in the composition according to ejection fraction, left ventricular score, history of myocardial infarction, and congestive heart failure score were in the direction of less severe disease but were smaller.
Univariate Survival Results
A selection of univariate results is reported here for survival rates at the median follow-up time of 12 years. Survival rates at other time points are included in the figures. As expected, the anatomic extent of disease was Fig 2) .
The impact of the congestive heart failure score on survival is dramatic. Fig 3 illustrates Fig 4A) .
Within the one-, two-, and three-vessel disease subgroups, ejection fraction remains a very important predictor of survival Twelve-year survival in patients with three-vessel disease and ejection fractions in the ranges of 50% to 100%, 35% to 49%, and <35% was 58%, 35%, and 10%, respectively (P<.0001, Fig 4B through   4D ). For each ejection fraction category, survival decreased according to the number of vessels obstructed (Fig SA through SC) .
It was hypothesized that the presence of proximal obstruction has an impact on survival beyond the number of diseased vessels. The univariate analysis indicates that the presence of a proximal obstruction is important to survival within the one-, two-, and three-vessel disease subgroups (P<.0001, Fig 6A through 6C) . However, the presence of proximal obstruction was not found to be significant at the P=.10 level in the multivariate analysis.
A history of myocardial infarction before enrollment had a clinically significant impact on long-term survival in this population. The 12-year survival of medically treated patients without a prior myocardial infarction was 84%, compared with 65% for patients with one myocardial infarction and 47% for patients with two or more prior myocardial infarctions (P<.0001, Fig 7) .
Patients who never smoked had better survival than those who were current or former smokers, with 12-year survivals of 78%, 72%, and 70%, respectively (P<.0001, Fig 8A) . The Fig 9B) . Among the patients presenting with threevessel disease, 27% of those without a proximal obstruction remained on medical therapy, whereas only 15% of those with three proximal obstructions remained on medical therapy (P<.0001, Fig 9C) . Fig 9D shows The final regression model for rate to CABG is shown in Table 2 . Myocardial jeopardy score and angina variables were found to be the most significantly associated with surgery. Patients with anterior wall jeopardy had surgery at a higher rate than those with no jeopardized segments or only inferior wall jeopardy. Surgery rates increased with increasing severity of angina, presence of >50% LMCA stenosis, number of operable vessels, and number of proximal vessels diseased. The negative association between ejection fraction and surgery remained after adjustment for the variables in the regression model. Other variables associated with lower rates of surgery were diabetes, higher congestive heart failure scores, lower left ventricular scores, smoking by men (but not by women), previous myocardial infarction, and age >65 years. The negative effect of a previous myocardial infarction was found to be larger in women. The negative association between smoking and surgery in men, along with the lack of such in women, is shown in Fig 11A and llB. 
PTCA Results
Although the overall percentage of patients ever receiving PTCA was relatively small (3.5%), the proportion of patients receiving PTCA whose initial treatment was medical was found to be significantly different from the proportion whose initial treatment was surgical (2.7% versus 4.8%, P<.0001, Fig 12) . The numbers of patients receiving PTCA, classified by initial therapy, are shown in Table 4 . Of 809 patients who eventually had PTCA one or more times, 412 had been treated initially with surgery, whereas 397 initially had medical treatment. Of the 397 who were initially treated medically and eventually had PTCA, 220 never received CABG, 44 had PTCA followed at some time by surgery, and 125 had PTCA after surgery. These treatment histories are summarized in Fig 13. that patients in this population were more likely to receive PTCA if their initial therapy was surgery and were more likely to receive PTCA after surgery, even if their initial therapy was medical. Although the simple percentages in Table 4 and Fig 13 do 22 484 96.5 809 3.5 23 293 100 *The proportion of medically treated patients receiving subsequent percutaneous transluminal coronary angioplasty (PTCA) is significantly different from the proportion of surgically treated patients receiving subsequent PTCA, P<.0001 (based on 88% complete long-term follow-up for these procedures). In 174 registry patients, initial therapy was unspecified.
death from coronary artery disease becomes great. The second is that in women with coronary artery disease, the disorder may progress less rapidly than in men with similar disease. This second possibility might be realized through hormonal differences mediating lipid levels.12-'4 Both mechanisms may play a role in generating the sex results discussed above.
The number of proximal diseased vessels is another variable that may be highly affected by confounding or modeling complexity. It was hypothesized that the number of proximal diseased vessels has an impact on long-term survival because of the amount of "jeopardized" myocardium, independent of other variables. 15 examined because of their huge number and complexity. The issue of selective removal of patients in this population needs to be considered when the results of this analysis are interpreted. As in previous studies of this nature,1,17'18 since patients were removed from the survival analysis at the time of revascularization, the univariate results reported here do not necessarily describe the survival history that would have been seen in the absence of an option for alternative therapy. The Kaplan-Meier curves depict the long-term survival history of CASS patients in relation to patient characteristics, given that these patients remained on medical therapy under the surgical selection procedures of the time. However, it is important to note that if all patient characteristics that are related to both selection for surgery and survival are included in the Cox survival model, then the estimated hazard ratios for the patient characteristics will not be affected by selective removal of patients for surgery. 6 The unadjusted survival percentages for subgroups of this population must be interpreted in the context of both the medical therapies used over the time course of observation and the determinants of surgery at the time. It would be difficult to use the 12-year survival percentages presented here for direct comparison with other patient populations, since it would be hard to establish direct comparability of the populations over time. It would also be inappropriate to compare the survival percentages observed here with those of patients receiving surgery, since the groups would, in general, not be comparable: the average patient profile in the surgical group would be that of a patient who, it was believed, would benefit from surgery, whereas a large percentage of CASS patients who remained on medical therapy will have had profiles suggesting no benefit from surgery at the time.
With 
Appendix
The following are the variables tested in the stepwise regression, along with their definitions and abbreviations (in parentheses) used in the figures. All variables had "missing data" codes.
Ejection fraction (EJECFR). This was measured as described above.
Number of diseased vessels (DISVES). Each segment was scored on a scale of 1 to 6: 1, normal; 2, moderate hypokinesis; 3, severe hypokinesis; 4, akinesis; 5, dyskinesis; and 6, aneurysmal.
Myocardial jeopardy score (MYOJEP score). This score ranges from 0 to 3: 0, neither inferior nor anterior jeopardy; 1, inferior jeopardy alone; 2, anterior jeopardy alone; and 3, both inferior and anterior jeopardy. "Jeopardy" was evaluated in terms of whether there were severely diseased coronary vessels leading to "viable" anterior or inferior basal segments. Anterior jeopardy requires that the three anteroapical ventriculographic segments have either normal or hypokinetic motion and that these segments are jeopardized by lesions with >70% stenosis in the LMCA or proximal or mid LAD artery. Inferior jeopardy requires that the inferoposterior and diaphragmatic ventriculographic segments have normal or hypokinetic motion jeopardized by lesions with >70% stenosis in the proximal or mid RCA or, alternatively, in a left dominant system, by LMCA or proximal circumflex lesions. Unstable angina. This was coded as present or absent and defined as new or changing patterns of ischemic pain occurring within 2 months before arteriography.
Anginal class (CH Class). Anginal class was scored according to the Canadian Heart Association scoring or rest angina: 0, no angina; I, ordinary physical activity does not cause angina; II, slight limitation of ordinary activity due to angina; III, marked limitation of ordinary physical activity due to angina; and IV, inability to carry on any physical activity without discomfort due to angina. Rest angina is defined as angina unrelated to exertion.
Congestive heart failure score (CHF SCR). This score ranges from 0 to 4. One point is counted for the presence of each of the following four items: history of congestive heart failure, use of digitalis at enrollment, use of a diuretic at enrollment, and presence of rales on physical examination.
History of prior myocardial infarction. Illness count. This is a count of illnesses other than diabetes, ranging from 0 to 12. One point is counted for a history of any of the following types of disease: hypertensive, cerebrovascular, peripheral arterial, valvular heart, chronic pulmonary, thrombophlebitic, hepatic, renal, gout, neoplastic, peptic ulcer, or other.
